Thomas G. Wollman

Consumers Pay When Generic Drug Companies Collude. Here’s a Way to Stop Them.

Price-fixing by pharmaceutical cartels can cost billions, and the threat of lawsuits isn’t enough to deter it.

Researchers: Amanda Starc and Thomas G. Wollman